Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
39.98
+0.89 (2.28%)
At close: May 12, 2026
SHA:688163 Market Cap
SHA:688163 has a market cap or net worth of 4.33 billion as of May 12, 2026. Its market cap has increased by 142.60% in one year.
Market Cap
4.33B
Enterprise Value
3.57B
Revenue
197.68M
Ranking
n/a
PE Ratio
74.67
Stock Price
39.98
Market Cap Chart
Since March 11, 2022, SHA:688163's market cap has decreased from 5.98B to 4.33B, a decrease of -27.70%. That is a compound annual growth rate of -7.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 4.33B | 83.65% |
| Dec 31, 2025 | 2.36B | 23.97% |
| Dec 31, 2024 | 1.90B | -12.16% |
| Dec 29, 2023 | 2.16B | -5.22% |
| Dec 30, 2022 | 2.28B | -61.86% |
| Mar 11, 2022 | 5.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Assure Tech (Hangzhou) | 4.74B |
| Zhejiang Wecome Pharmaceutical Company | 4.50B |
| Hinova Pharmaceuticals | 4.50B |
| Hefei Lifeon Pharmaceutical | 4.41B |
| Shanghai Obio Technology (Group) Corp. | 4.28B |
| Boji Medical Technology | 4.27B |
| Pulike Biological Engineering | 4.00B |
| Baolingbao Biology | 3.94B |